Lyell Immunopharma (LYEL) Research & Development (2020 - 2025)
Historic Research & Development for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to $28.2 million.
- Lyell Immunopharma's Research & Development fell 2867.85% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.1 million, marking a year-over-year decrease of 870.12%. This contributed to the annual value of $171.6 million for FY2024, which is 619.97% down from last year.
- Latest data reveals that Lyell Immunopharma reported Research & Development of $28.2 million as of Q3 2025, which was down 2867.85% from $34.9 million recorded in Q2 2025.
- Lyell Immunopharma's 5-year Research & Development high stood at $48.7 million for Q4 2024, and its period low was $19.3 million during Q4 2021.
- Moreover, its 5-year median value for Research & Development was $41.6 million (2022), whereas its average is $39.9 million.
- In the last 5 years, Lyell Immunopharma's Research & Development tumbled by 5219.24% in 2021 and then soared by 9721.03% in 2022.
- Lyell Immunopharma's Research & Development (Quarter) stood at $19.3 million in 2021, then soared by 97.21% to $38.0 million in 2022, then increased by 23.57% to $47.0 million in 2023, then increased by 3.56% to $48.7 million in 2024, then tumbled by 42.11% to $28.2 million in 2025.
- Its Research & Development was $28.2 million in Q3 2025, compared to $34.9 million in Q2 2025 and $43.4 million in Q1 2025.